Craniosynostosis is a condition of complex etiology that always involves the premature fusion of one or multiple cranial sutures and includes various anomalies of the soft and hard tissues of the head. Steady progress in the field has resulted in identifying gene mutations that recurrently cause craniosynostosis. There are now scores of mutations on many genes causally related to craniosynostosis syndromes, though the genetic basis for the majority of nonsyndromic cases is unknown. Identification of these genetic mutations has allowed significant progress in understanding the intrinsic properties of cranial sutures, including mechanisms responsible for normal suture patency and for pathogenesis of premature suture closure. An understanding of morphogenesis of cranial vault sutures is critical to understanding the pathophysiology of craniosynostosis conditions, but the field is now poised to recognize the repeated changes in additional skeletal and soft tissues of the head that typically accompany premature suture closure. We review the research that has brought an understanding of premature suture closure within our reach. We then enumerate the less well-studied, but equally challenging, non-sutural phenotypes of craniosynostosis conditions that are well-characterized in available mouse models. We consider craniosynostosis as a complex growth disorder of multiple tissues of the developing head, whose growth is also targeted by identified mutations in ways that are poorly understood. Knowledge gained from studies of humans and mouse models for these conditions underscores the diverse, associated developmental anomalies of the head that contribute to the complex phenotypes of craniosynostosis conditions presenting novel challenges for future research.
Introduction
Craniosynostosis is a complex condition that always involves premature fusion of one or more cranial vault sutures. It affects approximately one in every 2000-2500 newborns 1,2 , making it the second most common craniofacial anomaly after orofacial clefts. It occurs across all geographic regions, in all ethnic groups, and across socioeconomic statuses 3, 4 .
Cranial sutures are fibrous joints consisting of two opposing osteogenic bone fronts separated by a mass of undifferentiated mesenchymal cells. Cranial vault sutures of modern mammals are evolutionarily derived from functioning cranial joints of the primitive, kinetic vertebrate skull, such as those found in extant fish 5 . The sutures in skulls of modern mammals allow temporary deformation during parturition or compression during trauma, inhibit bone separation for the protection of underlying soft tissues, and most importantly for craniosynostosis, serve as growth sites for cranial bones in the developing skull 6, 7 , allowing rapid bone formation and growth along the edges of the two opposing bones until they ossify and fuse postnatally. When sutures close prematurely, osseous unification of the two bones prevents growth at the fused suture and redirects it to other patent sutures, altering the global shape of the skull in predictable ways (Figure 1 ).
Research in genetics and developmental biology accomplished during the last two decades has focused on understanding how gene mutations alter the precise balance between cranial vault bone formation and patency at the suture. These data underlie our current understanding of cranial suture biology and the molecular and developmental pathogenesis of premature suture closure. In sum, the findings highlight the complex pathogenesis of craniosynostosis by identifying local aberrations in cell behaviors and tissue growth that could also contribute to a multitude of craniofacial developmental anomalies beyond premature suture fusion and reveal craniosynostosis conditions as complex clinical entities.
The study of craniosynostosis has a long history and many of these original ideas still permeate current craniosynostosis research. Hippocrates was the first to describe the relationship between the relative position of abnormally closed cranial sutures and the resulting shape of the head 8 . While Vesalius 9 and della Croce 10 provided elegant descriptions and illustrations of the cranial dysmorphology associated with craniosynostosis, our understanding of craniosynostosis was incomplete until Sömmerring and Gibson independently established the role of sutures as growth sites and deduced the impact of premature suture fusion on cranial morphology 11, 12 . Otto developed Sömmerring's work and established the idea that premature suture fusion would restrict growth of the skull and redirect growth of the underlying soft tissues to alter the gross morphology of the cranium, an idea that was formalized in 1851 by Virchow 11, 13 . Virchow proposed that when a cranial vault suture fused prematurely, growth of the vault was restricted in the direction perpendicular to the suture which led to expansion of the adjacent unaffected sutures and localized compensatory overgrowth in a direction parallel to the fused suture 14 . Jane and colleagues developed Virchow's ideas into an understanding of how a single fused suture causes compensatory growth at all neighboring sutures 15, 16 .
As part of his functional matrix hypothesis, Moss proposed that craniosynostosis is initiated by abnormalities of the early forming endochondral bones of the cranial base and that growth of the brain transmits biomechanical forces to later developing cranial vault bones through their attachments to the dura mater [17] [18] [19] , the outermost meningeal layer that along with cranial vault bone periosteum is derived from the ectomeninx (Figure 2 ). Dura mater encloses the brain, lines the endocranial surface of cranial vault bones and forms fibrous dural reflections that in humans attach to the cranial base along the lesser wings of the sphenoid, at the crista galli of the ethmoid, and along the crest of the petrous portion of the temporal bones 17 . According to Moss this physical coupling between the dura mater and the cranial base facilitates the transmission of information pertaining to brain expansion between the cranial base and the cranial vault, and in the case of craniosynostosis, could produce premature suture fusion 17 . Though descriptive, the importance of Moss' contribution is the recognition of the role of a changing system during growth and that all cells, including bone cells, grow in response to specific functional (biomechanical) demands of surrounding tissues.
Various classification systems have been developed to help make sense of the variation in craniosynostosis phenotypes. First, craniosynostosis can be characterized as simple or compound. Simple craniosynostosis involves fusion of a single suture, whereas compound craniosynostosis includes premature closure of two or more sutures 20 . Craniosynostosis can also be classified as primary or secondary. Primary craniosynostoses are conditions in which suture fusion is the consequence of a developmental disorder that directly targets the suture, while secondary craniosynostosis includes those conditions in which premature suture fusion is secondary to another known abnormality, often associated with central nervous system, metabolic, or hematological disorders and diseases 20, 21 . Finally, craniosynostosis can be classified as syndromic -occurring as one of a suite of traits or symptoms that consistently co-occur and characterize a syndrome -or as non-syndromic (or isolated), where premature suture fusion is the most obvious phenotypic anomaly and the genetic cause is unknown.
Approximately 92% of craniosynostosis cases are non-familial and 85% are nonsyndromic 11, 22 . The other 15% of cases are diagnosed with one of the nearly 200 known craniosynostosis syndromes, and about half of these follow a Mendelian pattern of inheritance [22] [23] [24] . The frequency of fusion of each of the cranial sutures varies, with the sagittal suture ( Figure 3 ) being the one most often fused in cases of isolated craniosynostosis. The coronal suture ( Figure 3A) is the suture that is the next most often prematurely fused, occurring in 20-30% of all cases of craniosynostosis, syndromic and isolated 25, 26 . Females are more commonly affected in cases of coronal craniosynostosis, whereas males are more commonly affected in cases of sagittal craniosynostosis. Craniosynostosis of one coronal suture (unicoronal craniosynostosis) occurs twice as often as bicoronal craniosynostosis. Synostosis of the metopic suture had a reported prevalence of 6-7 in 100,000 live births in 2000, but this incidence may be increasing 27 . Finally, premature fusion of the lambdoid suture ( Figure 3A) is relatively rare, estimated to represent about 1% of all craniosynostosis cases. Each case of craniosynostosis presents with fairly predictable changes in the shape of the cranial vault, along with associated variable dysmorphologies of the craniofacial complex ( Figure 1 ).
The complex nature of craniosynostosis is reflected in the difficulty in obtaining satisfying therapeutic treatments. Despite the tailoring of surgical approaches to individual needs, modern surgical treatment for craniosynostosis conditions has remained relatively unchanged, involving endoscopic strip craniectomy and helmet molding in the simplest cases [28] [29] [30] and single or repeated reconstructive surgeries in the more complex cases 31, 32 , with little means to predict surgical outcome. That reconstructive surgeries commonly initiated during the first year of life do not uniformly provide satisfying results and need to be repeated in some cases confirms that processes of postnatal growth and development are working against the morphological correction achieved by the surgeon and identifies craniosynostosis conditions as growth disorders 33 . Consequently, understanding prenatal and postnatal craniofacial development and growth is critical to developing therapeutics for this complex disease.
Cranial morphogenesis
The adult human skull is composed of twenty-two bones that form the neurocranium and the facial skeleton. Additionally, three separate bones that comprise the osseous portion of the inner ear are contained within the petrous portion of the temporal bone and the nonarticulating hyoid bone lies just superior to the thyroid cartilage to assist in functions of the tongue, larynx, and pharynx. In general, single skull bones develop either through the formation of single "ossification centers" (islands of mineralizing tissue) or by the union of multiple distinct ossification centers. As individual bones expand and begin to take on their unique shape, they approach one another but remain separated by the formation of sutures ( Figure 3A ,C).
Process of ossification and cells that make bone
Islands of mineralizing tissue destined to become bones of the cranial vault begin to form from neural crest-or paraxial mesoderm-derived mesenchyme between 23 and 26 days 34 of human fetal development. In humans and several vertebrate model organisms, neural crest cells establish the anterior and lateral portions of the cranial vault, including the frontal bones and the squamous portion of the temporal bones, along with many bones of the face and the anterior segments of the osseous cranial base [35] [36] [37] [38] (Figures 3, 4A ). In humans and mice, the posterior portion of the cranial vault, including the parietal bones, the lateral aspects of the interparietal (when present, as in mice [ Figure 3D ]), and the squamous occipital in humans 35, 36 are derived from paraxial mesoderm, along with the exoccipital and basioccipital portions of the occipital bone, and the petrous portion of the temporal bone (Figures 3, 4A ). In mice, the mid-section of the interparietal receives contributions of neural crest cells. As streams of these two cell populations successfully migrate to their targets, they interact with local epithelial cells and locally secreted factors that induce the formation of cell condensations 39 . At the condensation stage, mesenchymal osteoprogenitor cells take one of two paths to osteogenesis: 1) mesenchymal cells differentiate directly into osteoblasts to form bone through intramembranous ossification; or 2) mesenchymal cells follow a chondrogenic path in which they differentiate into chondroblasts that form cartilage anlagen that are eventually replaced by bone through endochondral ossification 40 ( Figure 4B ). Angiogenesis is known to be necessary for endochondral bone formation and evidence is accruing to establish the critical role of angiogenesis during intramembranous bone formation, as growing vessel networks not only provide a source of circulating factors and cells to previously avascular sites, but their migrating endothelial cells are an active part of the regulatory network underlying bone formation 41 .
is formed, and cells of the mesenchymal condensation pass through a pre-osteoblast stage and differentiate directly into osteoblasts 42 ( Figure 5 ). Intramembranous ossification of the cranial vault bones is initiated by condensation of mesenchymal cells between the dermal epithelium and the forming meninges ( Figure 2A ). As these cells differentiate along an osteogenic path, they first synthesize and secrete collagen type I fibers in a random fashion 43, 44 , along with bone sialoprotein and osteocalcin 45 , followed by polarized bone matrix 46 . Once the initial bone forming matrix (osteoid) is established, osteoblasts deposit hydroxyapatite to mineralize the matrix and continue to deposit osteoid along the periphery of the forming bone. As the osteoid expands and mineralizes, osteoblasts become trapped within the bone matrix where they either undergo apoptosis or differentiate to function as osteocytes 47 (Figure 5 ). Intramembranous ossification of the facial bones occurs primarily within condensations of osteogenic mesenchyme of the facial prominences and the maxillary and mandibular prominences of the first pharyngeal arch 48 .
In endochondral ossification, aggregated mesenchymal cells differentiate into chondroblasts and form cartilage that is later replaced by bone 49 . Initially, chondroblasts condense and subsequently differentiate into chondrocytes that proliferate rapidly to form an avascular cartilage "model" (anlagen) in roughly the shape of the forming element 50 . Unlike bone, these cartilage models can grow by accretion and interstitially as chondroblasts proliferate. Once differentiated, chondrocytes eventually stop dividing and increase in volume to become hypertrophic chondrocytes, some dying by apoptosis. As these large chondrocytes die, the surrounding cells, some of which are delivered by invading blood vessels, differentiate into osteoblasts that produce bone matrix and eventually replace the cartilage with bone 34, 51 . Although intramembranous and endochondral ossification have traditionally been thought to be separate processes, new research has shown that hypertrophic chondrocytes can survive and directly differentiate into osteoblasts, showing evidence for a "chondrocyte-to-osteoblast continuum," contributing to endochondral bone formation and postnatal bone repair 52, 53 (Figure 5 ).
Osteocytes form inter-cellular communication networks that convert mechanical signals delivered to bone into biomechanical signals that contribute to the regulation of bone formation and turnover executed by osteoblasts and osteoclasts during bone modeling and remodeling 54 . During bone modeling, defined as either bone formation by osteoblasts or bone resorption by osteoclasts on a given surface, the skeletal elements acquire their overall morphology and mass and go through the shape changes necessary for growth, but resorption and formation are not coupled at this stage 50, 55 . Bone remodeling, by contrast, renews and rebuilds the skeleton and involves bone resorption and formation that occur sequentially and in a coupled manner on a given surface 50, 54 .
The cranial base and facial skeleton in humans
Though the focus of craniosynostosis research is on the premature fusion of cranial vault sutures, isolated analysis of bones of the cranial vault does not acknowledge the fundamental connection of the vault with the rest of the skull. The osseous cranial base is composed of parts of the occipital bone that surround the foramen magnum, much of the sphenoid, the petrous portion of the temporal bones, and parts of the ethmoid and the vomer. Due to its positioning beneath the brain, the cranial base provides a structural connection between the cranial vault (above) and facial skeleton (below).
The cranial base forms as an element of the chondrocranium, a portion of the endoskeleton that functions to protect the embryonic brain and three principal sense organs. The complex development of the chondrocranium has been covered elsewhere [56] [57] [58] . Generally speaking the chondrocranium serves as an embryonic a template that is replaced by bone later in development. The significance of the chondrocranium to head development has been attributed to the interstitial growth of cartilage, which enables rapid production of complex structures as well as their continued growth during embryonic development of the head 56 .
Cartilaginous joints called synchondroses form between some of the bones of the cranial base and serve as important growth sites. Cranial synchondroses consist of two endochondrally ossifying bone fronts closely bonded by a specialized hyaline growth cartilage. Cranial base synchondroses make substantial contributions to anteroposterior expansion of the skull as the brain grows.
The facial skeleton forms from a series of distinct facial primordia including the frontonasal process, the paired maxillary processes, and the paired mandibular processes, together with certain elements of the more caudally forming pharyngeal arches 59 . Early in facial development, neural crest cells migrate from the border of the neural and surface ectoderm towards their facial targets physically interacting with head ectoderm, mesoderm and endoderm and exchanging signals to shape a series of complex units of the developing face including skeletal precursors.
The development of facial bones is exceedingly complex because of the number of bones involved and because their anlagen develop within facial processes that dynamically grow outward, rotate, and fuse in response to tissue interactions under the direction of a multitude of morphogens 48, [60] [61] [62] . Facial bones are primarily ossified intramembranously and can form from the coalescence of several ossification centers (e.g., maxillae), or from single centers (e.g., zygomatic bones). Individual bones of the upper and midface meet at sutures that when patent contribute to facial growth but less is known of the properties of facial sutures (but see 63 ).
The cranial vault in humans
In humans, each frontal bone ossifies from a single center, which appears between 6 and 7 weeks in utero 34 . The two human frontal bones abut at the metopic suture ( Figure 3A ), which is composed of cells of neural crest origin ( Figure 4C ), and is the first cranial vault suture to undergo fusion, typically beginning during infancy at approximately 9 months, with fusion usually completed by 2-4 years of age 34 . Unlike humans, the anterior portion of the murine interfrontal suture (the murine equivalent of the human metopic suture) remains open throughout life as do most murine cranial sutures 64 ( Figure 3C ). Human parietal bones appear approximately 7-8 weeks in utero 34 , and when fully formed, the left and right parietal bones border the sagittal suture, which is composed of cells derived from both neural crest and paraxial mesoderm cells ( Figure 4C ). Growing frontal and parietal bones overlap at the coronal suture, which is also derived of both neural crest and paraxial mesoderm 35 ( Figure 4C ).
Other bones that contribute to the human cranial vault are:
• the squamous portion of the temporal bone, which starts to mineralize intramembranously in the 7 th or 8 th week in utero 34 ;
• the intramembranous lateral surface of the greater wing of the sphenoid bone, which joins with the alisphenoid (formed in mice by intramembranous and perichondral ossification as an extension from the ala temporalis cartilage) to ossify about 9-10 weeks during human fetal developmental 34 ;
• the squamous portion of the occipital bone which has intramembranous (the most superior part of the squama that corresponds with the murine interparietal bone ( Figure 3B )) and endochondral (the supra-occipital) contributions 65 . By the 3 rd month of fetal development, these two ossification centers expand as they mineralize further and fuse to form the squamous occipital 65, 66 .
At birth in humans, the occipital bone is represented by four mineralized bodies: the squamous occipital (fused supra-occipital and interparietal), the left and right ex-occipital elements incorporating the occipital condyles, and the basioccipital. These latter portions of the occipital bone form endochondrally and surround the foramen magnum, but all occipital elements fuse into a single occipital bone postnatally. The parietal and occipital bones meet at the lambdoid suture where they overlap.
Increase in size of the cranial vault is primarily driven by the growing brain [67] [68] [69] . In humans, the brain reaches two-thirds of its adult size within the first two years of life, achieving adult size between 6-10 years of age 70 . Sutures are important growth sites, allowing the cranial vault bones to add tissue along the sutural edges to accommodate, protect, and keep pace with the growing brain. However, because sutures form and close at different times, the amount of growth accomplished by different cranial vault sutures is not uniform 71 . For example, the human metopic suture is invariably fused by 4 years of age so that the majority of subsequent sutural growth of the anterior cranial vault occurs primarily at the sagittal and coronal sutures 71 . Since bone is added at the osteogenic fronts of opposing bones of a suture, the direction of growth accomplished by a suture is perpendicular to the orientation of the respective suture (e.g., the orientation of the sagittal suture is anteroposterior, so growth local to this suture increases the mediolateral dimension of the skull) and continues throughout brain growth 71, 72 . Although bone is added at the osteogenic fronts contributing to size increase, cranial vault bones continually adjust their shape while increasing their size through modeling and remodeling of their inner and outer surfaces to maintain a consistent fit with the surface of the growing brain and other neighboring soft tissues.
When a cranial vault suture fuses prematurely, growth arrest occurs at the fused suture and further growth occurs local to still-patent sutures altering growth trajectories and producing changes in cranial vault shape ( Figure 1 ). It is assumed that the rapidly growing brain experiences localized compression when a suture closes prematurely that results in increased intracranial pressure, especially in individuals with multiple premature suture closure [73] [74] [75] , though direct measures of intracranial pressure are rare.
Mesenchymal cells of the suture provide an engine for cranial vault growth
Cranial vault sutures are fibrous joints that consist of two osteogenic bone fronts and an intervening cellular mass of undifferentiated mitotic mesenchymal cells ( Figure 6 ), all of which are bounded by the surface of the osteogenic layer (superficial) and the external surface of the dura mater (deep) 63 . Experimental studies on fetal and neonatal rat coronal suture development showed that removing the ecto-periosteal layer did not affect the development or maintenance of the coronal suture 76 , but absence of dura mater in newly formed coronal sutures caused obliteration of the suture 77, 78 , indicating that signals from (or mediated through) the dura mater are required to maintain patency of the suture once the bone fronts on either side of the coronal suture overlap. However, the initial formation of the coronal suture may occur in the absence of dura mater, possibly in response to inductive signals from the nearby bone fronts 6, 79, 80 .
The cellular composition of a suture is characterized by a mass of undifferentiated mesenchymal cells occupying the center of the suture, surrounded by a graduated series of cell types that are progressively more committed to an osteogenic fate, from pre-osteoblasts to differentiated osteoblasts, as one moves toward the cells defining the bone front 63, 81 ( Figure 5 , 6C, 6D). A complex set of instructions emanating from the major cellular signaling pathways (WNTs, BMPs, FGFs, and others) interact to direct particular subpopulations of these cells to become osteoblast lineage cells and progress along an osteogenic fate 42 . Expression of Runx2, known as a master regulator for osteoblast differentiation, delineates cells that are committed to an osteogenic fate 82 . The undifferentiated and proliferating mesenchymal cells are key to the role of the suture in skull growth; they function to maintain separation between the dermal bones of the cranial vault and contribute to the regulation of growth of the skull as they differentiate towards an osteoblast fate. A constant population of undifferentiated mesenchyme is required to preserve suture patency. A subpopulation of these mesenchymal suture cells come to be osteoblast lineage cells that differentiate into osteoprogenitor cells and finally progress to mature osteoblasts that deposit and mineralize bone matrix, thus enabling localized bone growth 6 .
Little is known of the basis (i.e., genetic, biomechanical, environmental) for normal suture closure that naturally occurs later in life in humans and most of what we know of the genetic mechanisms underlying suture closure comes from the study of premature suture fusion in mouse models for human craniosynostosis mutations. Gene expression patterns distinguish various sutures and suture subregions over space and time [83] [84] [85] [86] , and most of the current mechanisms considered causative for premature differentiation of osteoblasts, mineralization of sutural mesenchyme, and suture fusion represent aberrant genetic signaling, either occurring at the wrong place, at the wrong rate, or at the wrong time, leading to changes in the activities of cells of the suture (e.g., apoptosis, proliferation, differentiation).
developmental time, and/or specific to processes regulated by the gene harboring the causative mutation or networks in which the gene interacts. For example, mutations in the fibroblast growth factor receptors (FGFRs) can cause accelerated cell differentiation at the osteogenic fronts, as well as within the suture matrix 90, 91 , while mutations in MSH Homeobox 2 (MSX2) 92 cause accelerated cell proliferation at the osteogenic bone fronts and reduced apoptosis in the suture 6, 93 .
It has long been known that suture patency requires that a sufficient population of mid-suture mesenchymal cells remain undifferentiated to keep the two bone fronts separated, but there is more than one way for this cell population to be lost. Recent findings implicate GLI1+ cells of the suture mesenchyme as the main mesenchymal stem cell population for adult craniofacial bone growth and development that maintains suture patency, gives rise to the osteogenic fronts, periosteum, and dura mater, and regulates formation of adult craniofacial bones 87 . Reduction of GLI1+ cells in the sutures of postnatal day 7 Twist1 +/− mice, a mouse model for Saethre-Chotzen syndrome, was associated with fusion of the coronal and frontopremaxillary sutures and arrested overall skull growth 87 . These findings highlight the role of specific suture stem cells in maintaining suture patency and provide exciting information regarding a specific aspect of the more global aspects of craniosynostosis phenotypes. Individual bone shapes are known to be different from normal in mouse models for craniosynostosis. Defects in this stem cell population would impact the number of cells available to build individual bones, thus constraining directions and magnitudes of growth, potentially affecting the quality and shape of bones, and contributing to overall craniofacial dysmorphogenesis.
Genetic contributors to cranial vault suture biology in craniosynostosis conditions
The idea that craniosynostosis is a genetic disorder arose shortly after Octave Crouzon 94 originally described craniosynostosis in a mother and child as "hereditary" due to the observation that they exhibited the same phenotype. By the 1930s, the dominant inheritance pattern present in certain types of craniosynostosis was recognized by at least some researchers 95 . However, identifying specific mutations in genes responsible for craniosynostosis (Table 1) awaited the advances in molecular genetics that transpired over the last 30 years. The first gene implicated as causative for craniosynostosis syndromes was for the relatively rare Boston-type craniosynostosis, a fully penetrant, autosomal dominant disorder with varying degrees of craniofacial dysmorphology 92, 96 . Boston-type craniosynostosis is caused by a mutation in MSX2, a conserved homeobox gene that is involved in regulation of inductive tissue interactions in embryogenesis 92 . Gain-of-function mutations in MSX2 cause premature suture fusion, and the loss-of-function mutations in MSX2 result in cranial vault ossification defects 97 .
Since these early discoveries, causative mutations for craniosynostosis syndromes have been verified in at least seven genes (FGFR1, FGFR2, FGFR3, TWIST1, EFNB1, MSX2 and RAB23) but additional genetic variants associated with craniosynostosis syndromes (see Table 1 ) and isolated craniosynostosis continue to be implicated [98] [99] [100] . Because of the knowledge of craniofacial sutures as growth sites, and the evident association of early closure with cranial vault morphology, most studies of gene action have focused on what happens within the suture when a causative mutation is present. Knowledge of the effects of these mutations on cell behaviors comes from the study of human cells from patients known to carry specific craniosynostosis-causing mutations and from the study of mouse models. A wealth of detailed information exists for each of the genes that carry mutations known to be causative for craniosynostosis, and with each new discovery, the complexity of the mechanisms involved and potential interaction among these factors in suture formation, maintenance, and fusion become more apparent. Here we provide a brief description of some of the mutations in genes known to cause craniosynostosis. Detailed explanations of the molecular signaling and interactions underlying how mutations in these major genes cause premature suture closure are available in several fine, in-depth reviews and the original reports cited within 22, 101, 102 (for FGFR see 45, [103] [104] [105] , for TWIST1 see 84, [105] [106] [107] [108] , for MSX2 see 106, 109 , for EFNB1 see 106, 107 , for RAB23 see 101 ).
Fibroblast growth factor receptors (FGFRs)
The most prevalent craniosynostosis syndromes (Apert, Crouzon, Pfeiffer, and Muenke syndromes) ( Figure 7 ) are caused by mutations in genes encoding FGFR1, FGFR2 and FGFR3 ( Figure 8 ) (Table 1 ). The FGF/FGFR pathway is a paracrine signaling pathway comprised of 18 ligands (FGF1-FGF10 and FGF16-FGF23) and four receptors (FGFR1-FGFR4) that play critical roles in cell functions and are active in many developmental processes as diverse and important as gastrulation, somitogenesis, and the development of the central nervous system, limbs, lungs, and vascular system [110] [111] [112] . Each of the FGFRs possess an extracellular region with three immunoglobulin-like (Ig) domains (D1-D3) for binding FGF ligands, a transmembrane domain, and a cytoplasmic tyrosine kinase domain 112, 113 . Different FGFs show distinct binding affinities for the individual FGFRs based on unique sequences in the N-and C-terminal tails of the FGFs and the immunoglobulin (Ig) domains of the FGFRs, as well as variation in the timing and location of their expression 113, 114 . FGF/FGFR binding, which is usually mediated by heparin sulphate glycosaminoglycan binding to the FGF, causes the FGFRs to dimerize and activate tyrosine kinase activity within the cell 113 .
Identification of mutations in FGFRs that cause skeletal dysplasia like achondroplasia 115 and craniosynostosis [116] [117] [118] [119] in humans revealed the importance of the FGF/FGFR signaling system in normal bone growth and development 45 . Craniosynostosis-causing sequence changes in the FGFRs are most commonly encoded in the extracellular portion of the gene, particularly in the linker region between Ig domains II and III 120 , and they act to produce gain-of-function mutations that assist dimerization of the FGFRs 121 . These mutations either alter the binding affinity for FGFRs toward all FGFs or a specific subset of FGFs 121,122 , or cause constitutive activation of the FGFR pathway, in which binding of an FGF ligand is not required to stimulate FGFR dimerization and intracellular activity 123, 124 . The downstream consequence of FGFR activation in the suture is the onset of runt-related transcription factor 2 (RUNX2) expression, essential for the differentiation of osteoblasts. Expression of RUNX2 leads suture mesenchyme cells to differentiate into osteoblasts that will deposit bone and eventually unify the two osteogenic fronts of the suture 125, 126 .
TWIST1
Increased knowledge of the intracellular components of the FGF/FGFR pathway ( Figure 8 ) has helped to identify additional craniosynostosis-causing genetic variants. Multiple genes that act as regulators or downstream effectors of the FGF/FGFR pathway have also been implicated in craniosynostosis syndromes. TWIST1, a basic helix-loop-helix transcription factor, is associated with Saethre-Chotzen syndrome (Figure 7 ) that typically includes craniosynostosis of the coronal suture (Table 1) [127] [128] [129] . A heterozygous loss-of-function mutation in TWIST1 results in increased osteogenic capability and causes suture closure through increased bone deposition [127] [128] [129] . TWIST1 is found in the developing suture mesenchyme and functions in all stages of osteoblast differentiation 80 . TWIST1 functions as a negative regulator of both FGFR2 and RUNX2 130, 131 .
TWIST1 and FGFR2-There are currently two non-mutually exclusive models for how TWIST1 regulates patency of the coronal suture. The first, established by Connerney et al., proposes that different TWIST1 dimers play a homeostatic role in regulating FGFR2 expression 84 (Figure 9 ). TWIST1 is able to form functional homodimers (T/T) as well as heterodimers with E proteins (T/E) 84 . One E protein that is known to heterodimerize with TWIST1 in the coronal suture, TCF12, has been implicated in coronal suture craniosynostosis 98 (see following). TWIST1 homodimers act as an FGFR2 agonist in cells of the osteogenic front, whereas TWIST1 heterodimers are found in suture mesenchyme cells, where they act as an FGFR2 antagonist 84 . The difference in TWIST1 dimer composition is mediated by ID (Inhibitor of DNA-binding/differentiation) proteins, which are expressed in the osteogenic front and bind preferentially with E proteins 84 . As a result, TWIST1 is forced to homodimerize in the osteogenic front because of decreased availability of E proteins 84 . In the suture mesenchyme, where ID proteins are absent, TWIST1 is able to dimerize with E proteins because of the lack of competition from ID. ID is upregulated by BMP signaling, which is itself upregulated by FGFR2 signaling, which downregulates expression of BMP antagonist noggin 84, 108 . This interaction between FGFR2, BMP, and ID creates a homeostatic regulation of FGFR2 that restricts its expression to the osteogenic front and prevents fusion of the suture. In Twist1 +/− mice, decreased expression of TWIST1 relative to ID results in increased formation of T/T dimers and decreased formation of T/E dimers, which increases the expression domain of FGFR2 into the suture, eventually resulting in suture fusion 108 .
TWIST1, EFNB1 and MSX2-The second model for how TWIST1 regulates coronal suture patency concerns the interaction between TWIST1 and the EPH/EPHRIN cell-to-cell signaling pathway in the coronal suture ( Figure 9 ). EPH/EPHRIN signaling operates through juxtacrine communicating junctions between membrane bound ligands (EPHRINs) and receptors (EPHs) 132 . While EPH/EPHRIN signaling is critical for multiple aspects of craniofacial development, including neural crest cell migration 133 and palatogenesis 134 , its relevance to premature suture fusion lies in its interaction with TWIST1 and MSX2 in the maintenance of the boundary between neural crest-derived and mesoderm-derived cells at the coronal suture 106, 107 . The coronal suture develops at a boundary between osteoblast lineage cells derived from neural crest that will form the frontal bone and those derived from mesoderm that will form the parietal bones 106 . TWIST1 and MSX2 function together to maintain the integrity of this boundary, and EPH/EPHRIN signaling has an important downstream role in this process. Disruption of the boundary occurs when osteogenic neural crest cells invade the mesoderm-derived undifferentiated mesenchyme of the mutant coronal suture and establish osseous connections between the frontal and parietal bones 106 ( Figure  10 ). In these experiments, haploinsufficiency of TWIST1 leads to expanded expression of MSX2 in the coronal suture, which coincides with reduced expression of EPHRIN-A2 and EPHRIN-A4 in the suture and the consequent invasion of osteogenic neural crest cells into the suture mesenchyme 106 . Further research showed that EPH/EPHRIN signaling acts downstream of TWIST1 to maintain the coronal suture boundary. Beyond this experimental research using mouse models, knowledge of the interaction of these genes in craniosynostosis is complemented by the discovery of coronal suture craniosynostosiscausing mutations in the human genes MSX2 92 , the ephrinB1 human orthologue EFNB1 135, 136 , and the ephrinA4 human orthologue EFNA4 106 .
Molecular Pathogenesis in Nonsyndromic Craniosynostosis
The genetic cause and molecular pathology for cranial suture closure is best defined in craniosynostosis syndromes. Relatively less is known of genetic causation in nonsyndromic craniosynostosis that represent 85% of all craniosynostosis cases, but that tide is beginning to turn as rare mutations are being identified in a small number of nonsyndromic craniosynostosis cases 22 . Individuals with nonsyndromic craniosynostosis rarely have abnormalities of the postcranial skeleton, and suture closure is considered an isolated anomaly. Subtle craniofacial anomalies in isolated craniosynostosis disorders are traditionally attributed to facial and cranial base growth disturbances that are caused by the premature closure of cranial vault sutures. Evidence is beginning to accumulate from humans and mice (see following section) to suggest that this assumption should be reevaluated. For example, three-dimensional quantitative analysis showed that the facial skeleton and cranial base are invariably different from normal in individuals with confirmed nonsyndromic coronal craniosynostosis 137 . Until the specific mechanisms by which a closing vault suture could cause facial and cranial base anomalies are defined, the idea that cranial vault suture closure causes change in facial and cranial base development resulting in the characteristic facial appearance of individuals with isolated craniosynostosis is a hypothesis requiring testing.
The facility of new genomic tools and technologies is bound to elevate the number of genes that can be readily identified with craniosynostosis conditions. Genome wide association studies (GWAS), whole exome, or even whole genome sequencing are certain to increase the number of craniosynostosis loci identified, and it is likely that many of the new variants will be members of already identified networks. For example, a GWAS 99 identified two susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and BBS9. Sharma et al. 98 recently used exome sequencing to identify 38 heterozygous TCF12 mutations in a relatively large sample of unrelated individuals with coronal craniosynostosis. They also showed that the dosage of TCF12-TWIST1 heterodimers is critical to coronal suture morphogenesis, a result consistent with previous work on Saethre-Chotzen syndrome. 
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More recently, mutations in ETS2 repressor factor (ERF) 138 and zinc finger protein of cerebellum 1 (ZIC1) have been found to cause coronal craniosynostosis. Heterozygous mutations in the ERF gene were implicated in both syndromic and nonsyndromic craniosynostosis, Chiari malformation, and language delay 138 . ERF binds close to regulatory sites controlled by RUNX2, and reductions in dosage of ERF can cause disruptions in RUNX2 activity, leading to changes in osteoblast differentiation in suture cells and premature suture fusion 138 (Figure 8 ). Individual family members with heterozygous mutations in the third exon of ZIC1 have a distinct phenotype that includes severe coronal craniosynostosis and variable learning disabilities 100 . Through the use of animal models, it is proposed that the effect of ZIC1 on cells occurs during early formation of the supraorbital regulatory center (early frontal bone) via a complex of signaling networks ultimately resulting in premature closure of the coronal suture and learning disabilities.
Beyond sutures: Craniofacial dysmorphogenesis in mouse models for craniosynostosis
Compared to cranial vault sutures, relatively little is known about how the mutations that recurrently cause craniosynostosis affect cranial cells and tissues to result in midfacial retrusion and other non-sutural phenotypes. The complexity of midfacial development and the diversity of mutations associated with craniosynostosis means that individual phenotypic contributions to generalized clinical entities associated with craniosynostosis conditions (e.g., midfacial retrusion, hypertelorism, cranial base diminution, palate deformities) may differ depending upon the specific mutation other genetic contributors and environmental inputs 139 . Evidence from studies of humans and mice is beginning to accumulate suggesting that a prematurely closed or dysfunctional suture could be necessary, but not sufficient, to produce the additional complex craniofacial phenotypes that typically define craniosynostosis conditions.
Many genes are conserved across mammals, and the proximate functions of most of those genes are likely conserved, as well 140 . Because humans share key developmental mechanisms with most other mammals, mouse models for many of the more common craniosynostosis syndromes have served as the primary workhorse of craniosynostosis research and have been used primarily to identify the aberrant genetic signaling leading to changes in the activity of osteoblast lineage cells of the suture. But these murine models mimic additional craniofacial anomalies that are known to occur in craniosynostosis conditions ( Table 1) . A number of excellent reviews have summarized the specific aberrant cellular and molecular mechanisms underlying premature suture closure in these animal models that have brought us to a clearer understanding of suture biogenesis 102, 141, 142 . Here we provide examples of the less well-studied non-sutural craniofacial phenotypes that characterize mouse models for craniosynostosis conditions. At this point the descriptions are primarily morphological but the availability of animal models provide a tool for analysis of additional aspects of cranial dysmorphogenesis that are worthy of study. 
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Mouse models for FGFR-related syndromes
Total disruption of FGFR1 and FGFR2 results in early embryonic lethality 143, 144 . To overcome lethality, conditional knockout mice have been created and used to study the role of FGFR signaling pathways in the regulation of bone formation throughout development 145, 146 . The Fgfr1 P250R/+ Pfeiffer syndrome mouse model 147 , carrying the murine P250R mutation (equivalent to human FGFR1 P252R mutation), provides valuable insight into the role of FGFR1 in intramembranous bone development 116, [147] [148] [149] [150] . The phenotype of Fgfr1 P250R/+ Pfeiffer syndrome mice exhibit premature fusion of the interfrontal, sagittal and coronal sutures and a skull that is shortened antero-posteriorly, laterally widened, and vertically heightened 147 . Accelerated osteoblast proliferation and increased expression of genes related to osteoblast differentiation local to the vault sutures suggests that bone formation is locally increased at the suture 147 . Accelerated osteoblast differentiation associated with early expression of RUNX2 suggested that RUNX2 is downstream of FGFR signaling and supported earlier evidence that FGFR1 is involved in osteoblast differentiation 71, 151 . While change in osteoblast activity that is localized to the sutures provides an explanation for early closure of the frontal and sagittal sutures, it does not account for changes that produce a relatively wide skull or midfacial retrusion, clearly evident in these mice. The authors attribute midfacial retrusion to primary craniosynostosis of the facial sutures, but also suggest that FGF signaling within the pharyngeal arches could also affect differentiation or proliferation of osteoblast lineage cells thereby contributing to maxillary retrusion 149 .
Mouse models for Apert syndrome have been developed on outbred 152, 153 and inbred 154, 155 genetic backgrounds. Models carrying dissimilar Fgfr2 mutations but on similar inbred backgrounds allow direct comparison of the effects of the mutation without the confounding influence of uncommon background genes. The Fgfr2 +/S252W and Fgfr2 +/P253R mouse models mimic many of the human craniofacial phenotypes associated with Apert syndrome and have been key in revealing that mutations in FGFR2 cause craniosynostosis through distinct mechanisms 142, [152] [153] [154] [155] [156] . Study of Fgfr2 +/S252W Apert syndrome mice show that fusion of the coronal suture is associated with an upregulation of osteogenesis through increased proliferation and failure of mechanisms that inhibit differentiation of cells of the sutural mesenchyme, driving the frontal and parietal bones into a single osteogenic domain 155 . In the Fgfr2 +/P253R mice 155 , abnormal osteoblastic proliferation, differentiation and osteogenesis, but no increased apoptosis, was observed in the coronal sutures.
Quantitative analysis of craniofacial phenotypes in mouse models for Apert syndrome show the brain, cranial vault, facial skeleton, and cranial base to be dysmorphic [157] [158] [159] . Consistent with early clinical investigations suggesting abnormal cartilage development of the cranial base as primary in craniosynostosis 160 , study of the Fgfr2 P253R mutation under the control of the Col2a1 promoter enhancer that limits the effects of the mutation to chondrocytes, led to the suggestion that the overall craniofacial dysmorphology of this mouse model is not simply a result of coronal suture closure, but that a primary disturbance in growth of the cranial base and precocious endochondral ossification also contribute 157 .
Quantitative study of three-dimensional data from micro-computed tomography (μCT) images show the facial skeleton, rather than the cranial vault to be the most affected region of the skull in newborn Fgfr2 +/S252W and Fgfr2 +/P253R Apert syndrome mice 88, 159 . Facial dysmorphology is more severe in Fgfr2 +/S252W Apert syndrome mice relative to Fgfr2 +/P253R mice, and is localized to the posterior palate where abnormal cellular proliferation, differentiation, and apoptosis is observed in the maxillary-palatine suture 88 . Analysis of additional facial sutures by μCT show early fusion (by E17.5) in Fgfr2 +/S252W and Fgfr2 +/P253R Apert syndrome mice contributing to differences in prenatal craniofacial growth patterns between mice carrying the Fgfr2 mutations and their unaffected littermates whose facial sutures remained patent 161 . In both Fgfr2 +/S252W and Fgfr2 +/P253R Apert syndrome mouse models, the 3D morphology of the skulls and select cranial soft tissues of mutant mice were statistically significantly different from those of their unaffected littermates at E17.5, a time at which their coronal sutures are patent 161 . Since facial and cranial base dysmorphology preceded coronal suture fusion that invariably occurs by birth in Fgfr2 +/S252W and Fgfr2 +/P253R Apert syndrome mice, it was proposed that fusion of the coronal suture is one of many dysmorphic features in these mouse models for Apert syndrome, rather than the cause of the global craniofacial dysmorphology 159 . However since changes in cellular and molecular mechanisms of the nascent coronal sutures were documented in these mouse models as early as E12.5-E13.5 162 , it is possible that cellular changes of the suture prior to fusion could change the growth potential of neighboring tissues and contribute to craniofacial dysmorphogenesis nonlocal to the suture.
The Fgfr2c C342Y/+ Crouzon syndrome mouse 163 exhibits many of the characteristic traits of Crouzon syndrome, including coronal suture fusion, domed shaped cranial vault, eye proptosis, midfacial retrusion, and occasional cleft palate. Quantitative analysis of 3D μCT and magnetic resonance microscopy images reveal local differences in skull morphology, coronal suture patency, brain shape but not brain size, and significant reductions in nasopharyngeal and eye volumes between Fgfr2c C342Y/+ mice and unaffected littermates at birth, providing an expanded catalogue of clinical phenotypes in this mouse model caused by changes in FGF/FGFR signaling 164 . Fgfr2c C342Y/C342Y mice show limb abnormalities such as joint fusions and broad first digits and lung and trachea defects, which are recorded in some human patients with Crouzon syndrome 163 .
Heterozygous mutants of another Crouzon syndrome mouse model, Fgfr2 W290R , present features similar to patients with Crouzon syndrome, exhibiting mild craniofacial anomalies at birth that become more severe with age 124 . On the basis of nasal cartilage malformation and missing presphenoid, these authors proposed that midfacial defects in some craniosynostosis syndromes are a direct result of the mutation on patterning and development of the midface rather than an indirect effect of other craniofacial dysmorphogenesis 164 . Malformed digits found in individuals with a severe form of Pfeiffer syndrome that carry the W290R mutation 165 are similar to anomalies found in the limbs of Fgfr2 W290R/W290R mutant mice 166, 167 . These homozygous mice exhibit constitutive FGFR2 activation with typical tissue-specific patterns, but increased expression of the IIIb and IIIc isoforms in many of the defective organs 167 .
The Fgfr3 P244R/+ Muenke syndrome mouse model carries the murine equivalent of the human Muenke syndrome mutation (FGFR3 P250R) 168 and has been informative in the study of craniofacial variation and the physiological mechanisms underlying hearing loss in patients with this syndrome 169 . Some human individuals with Muenke syndrome have phenotypic features that are not clearly distinguishable from other craniosynostosis syndromes including craniofacial dysmorphology, abnormalities visible on hand and foot radiographs, brachydactyly, and sensorineural hearing loss 170 . Others have few or no anomalies other than coronal craniosynostosis, and still others have only macrocephaly or normal head shape 171 . Because of the extreme phenotypic variation, clinical diagnosis of Muenke syndrome may be difficult and is verified by the presence of the FGFR3 P250R mutation.
Initial analysis of the Fgfr3 P244R/+ mouse model backcrossed to generate congenic lines in four different strain backgrounds provided a phenotypic profile for adult mice, paralleling a number of key traits found in human patients with Muenke syndrome but the skull phenotype was dependent on genetic background and sex, with males more often affected 168 . Homozygous mutants (Fgfr3 P244R/P244R ) are viable and their adult cranial phenotypes include a domed skull shape that shows premature fusion of the facial sutures, but an unfused coronal suture, short cranial base, and loss of hearing, but adult heterozygous (Fgfr3 P244R/+ ) mice have been reported with no overt skull abnormalities 71, 169 . On the other hand, phenotypes of rounded skull and shortened snout occur in adult Fgfr3 P244R/+ Muenke syndrome mice, even when the coronal suture remained patent, a result consistent with the presence of skull dysmorphogenesis in prenatal Apert syndrome mice, prior to coronal suture fusion 168, 169 .
A quantitative study of craniofacial morphology of an independently derived Fgfr3 P244R/+ mouse at E17.5 and at birth (P0), revealed many subtle craniofacial anomalies in heterozygous and homozygous mutants, along with premature fusion of the coronal and some facial sutures. Phenotypic variation and dysmorphology were greater in homozygous mice relative to heterozygotes 172 . Decreased alkaline phosphatase activity and RUNX2 expression was observed in the developing mandibles of Fgfr3 P244R/P244R embryos indicating that the mutation may repress ossification of the mandible. This localized process may also account for additional subtle skull anomalies of the facial skeleton and cranial base but needs to be further investigated.
Murine models of Saethre-Chotzen syndrome
The Twist1 +/− mouse, with only one functional copy of the Twist1 gene, mimics the clinical phenotype observed in Saethre-Chotzen syndrome 173,174, including coronal suture abnormalities and additional cranial and postcranial traits. Analyses of these models has provided an explanation of coronal suture closure based on the principal of developmental boundaries 87, 106, 107 . The separation of cells into distinct populations is accomplished by special mechanisms of cell affinity that are fundamental to development 175 . Boundaries are commonly formed between cell populations by cells that can simultaneously maintain the separation of cells while influencing the patterning of surrounding cells producing progressively finer subdivisions of a tissue 175, 176 . As discussed previously, cells of the coronal suture serve as a boundary between the domains of neural crest-derived cells destined to form the frontal bone and of mesoderm-derived cells that will form the parietal and prevent neural crest cells from crossing into the suture 177 . Disruptions in this boundary 
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Author Manuscript in Twist1 +/− mutant coronal sutures has been shown to result in premature coronal suture closure caused by neural crest cells crossing into the domain of undifferentiated mesoderm of the suture 87, 106, 107 , due to either the cells' failure to correctly interpret boundary signals or an anomalous ability to receive signals encouraging migration into the sutural mesenchyme.
Twist1 +/− mice showed reduced levels of TWIST1 that favors chondrogenesis and thereby induce endochondral ossification in the coronal suture between postnatal days 9 and 15 178 . At postnatal day15, in addition to premature fusion of the coronal suture, Twist1 +/− mutant mice have a consistent pattern of craniofacial dysmorphology affecting all major regions of the skull. The cranial vault is high (acrocephalic) and wide (brachycephalic), the facial skeleton is flat and wide, and the cranial base is shortened, not unlike the cranial morphology of children with Saethre-Chotzen syndrome 179 . The authors recognize these differences to at least partially be the direct result of the TWIST1 haploinsufficiency on the developing craniofacial skeleton 179 .
In summary, the consistent finding of anomalies of the facial skeleton, cranial base and select cranial soft tissues in human craniosynostosis conditions and in mouse models carrying the craniosynostosis-causing mutations demonstrates a strong relationship among these developmental phenotypes. Focus on the suture has provided in-depth knowledge of how these mutations change cellular activities local to the suture causing premature closure and cranial vault dysmorphogenesis. There is no doubt that premature closure of a vault suture will change cellular and tissue relationships in a growing head, and in this way, may contribute secondarily to dysmorphogenesis occurring nonlocal to the suture. But the causative mutations are on genes known to function extensively throughout development, so it seems probable that the primary effects of these mutations are not limited to the suture or to the cranial vault and can be contributing directly to the dysmorphogenesis of the facial skeleton and cranial base as well as additional tissues and organs of the head.
Perspective: acknowledging complexity to push the field forward
Currently there are three chief explanations for premature closure of cranial vault sutures that have been proposed from the scientific experiments reviewed here: 1) deviations in the activity of osteoblast lineage cells within the suture; 2) defects in boundary formation; and 3) reduction in suture stem cell populations. The specifics of the experiments that provide evidence for each of these three explanations are unique but all evidence clearly demonstrates how changes in instructions delivered to cells fundamental to developmental processes (i.e., proliferation, differentiation, apoptosis) cause sutures to close prematurely. Viewed in this way, each of the three explanations can be considered as varied aspects of a larger process. Knowledge of the diverse molecules associated with changes in suture patency is critical to understanding the mechanisms that link genes with sutural phenotypes and developing effective therapies, however, there is more to craniosynostosis than a closed suture. We propose an expanded definition of craniosynostosis from one that focuses uniquely on suture closure to one that includes additional craniofacial anomalies. Doing so will serve as an important tool to further our understanding of the genetic heterogeneity and developmental processes that underlie the spectrum of craniosynostosis phenotypes. 
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Analyses of human and murine craniosynostosis phenotypes reveal complex dysmorphology of many tissues of the head signifying that this condition comprises disruption in developmental mechanisms that are not limited to a suture, but encompass disturbances in overall cranial growth. Though our current knowledge of the processes involved in suture maintenance and premature closure is wonderfully detailed, these data provide only part of the picture. We have only a vague understanding of how the developmental basis of the welldefined sutural phenotypes might relate to associated anomalies of the cranial base and facial skeleton, or to soft tissue anomalies of the brain, nasopharynx, eyes, and other organs that commonly co-occur. Mutation-driven changes in the signaling of morphogens currently known to affect cranial vault suture patency by changing osteoprogenitor cell behavior might also directly alter the development of the facial skeleton and chondrocranium. The comorbidity of premature cranial vault suture fusion with cranial soft tissue anomalies suggests that craniosynostosis mutations may affect additional developmental mechanisms that directly target non-osteogenic tissues (e.g., affecting the morphology of the forming facial prominences thereby changing relationships among developing facial organs, spaces, and bones), but does not negate the possibility that these tissues also respond to the effects of prematurely closing cranial vault sutures. Fine-grained analyses of the molecular underpinnings of additional craniosynostosis anomalies, as well as growth of the head as a unit, are needed.
Mechanistic explanations for premature suture closure can help build hypotheses about how the signaling genes that cause craniosynostosis syndromes might also affect cells that are not in the osteoblast lineage. Since many craniosynostosis causing mutations are on genes that are active at many times and in many places during head development, disruption in the function of these pathways has the potential to establish additional cellular changes that impact mechanisms of cell affinity underlying non-osseous tissue boundaries, and cranial morphogenesis generally. For example, cranial soft tissue structures that form prior to cranial osteogenesis could be primary targets of aberrant FGF/FGFR signaling (e.g., FGFdependent pharyngeal endoderm of the primitive pharynx; FGF-dependent presumptive midbrain and first rhombomere) contributing fundamentally to the pathogenesis of nonsutural cranial phenotypes by modifying the physical arrangement or activities of cell populations, thus altering the location or nature of boundaries. Even subtle changes in physical arrangements of growing tissues could severely affect a cell's ability to respond to local signaling cues (physical or biochemical) during morphogenesis.
Decreasing mesenchymal stem cell (MSC) populations in the suture is the newest explanatory mechanism for craniosynostosis, and it opens novel avenues of research in overall craniofacial morphogenesis. Diminished suture stem cell populations are not only associated with premature suture closure, but also with change in volume of select cranial bones, cranial bone quality, cranial bone turnover, and overall skull size 87 providing a potential mechanism not just for localized changes such as early closure of a particular suture, but for the simultaneous disruption in individual bone development. The crucial role that MSCs play in bone formation further evidences the need to understand craniosynostosis conditions as an overall growth disorder, and not strictly as the loss of patency at one or more cranial sutures. Sutures are dynamic structures that change in size, shape, cellular makeup, and genetic signaling patterns throughout their initiation, growth, and fusion. MSCs 
Author Manuscript contained within the suture are similarly dynamic, as a single cell may be tasked with maintaining suture patency, depositing bone matrix, and directing bone modeling and remodeling as it differentiates along the osteogenic path.
The discrete nature of premature suture closure provides a reason for success in the investigation of causal factors. Unambiguously causal factors, like the mutations on genes that we have discussed (above and Table 1 ), are those that generate repeated errors of development and disease phenotypes. Premature suture closure may arise frequently in the presence of specific mutations, but may not in the presence of other mutations. The finding that the Fgfr3 P244R mutation has different effects on different strains of laboratory mice 168 and that the human equivalent (the human P250R mutation on FGFR3 causative for Muenke syndrome) produces remarkable phenotypic variation 171, 180 is evidence of this fact and could be further studied to clarify the basis for variation in the development of craniosynostosis phenotypes. The interaction of underlying genetic variants with environmental exposures also contributes to unique aberrations of development so that studies of gene-environment interaction will undoubtedly play an important role in explaining observed phenotypic variation in craniosynostosis. Several environmental risk factors have been suggested in the development of craniosynostosis 181, 182 including parity, prematurity, intrauterine constraint, and maternal tobacco or nitrosatable drug use, but overall, our knowledge of these effects and their individual and collective interaction with genes remains inconclusive. These complex relationships between environment and genetic mechanisms will need to be addressed, perhaps most efficiently through systems biology approaches, as we inch closer to identifying the major molecular contributors to those cases of craniosynostosis whose genetic cause is currently unknown.
An expanded definition of craniosynostosis that includes additional associated craniofacial anomalies opens new doors for research and will eventually allow a greater understanding of these complex growth disorders. However, an expanded definition does not refute the clinical and developmental importance of premature cranial vault suture closure or diminish the significance of the discoveries that we have reviewed here. The accumulated knowledge that we have presented about the closure of sutures is critical in the development of effective therapies, but as of this date, there is no evidence that targeting and preventing premature suture closure will ameliorate the accompanying craniofacial anomalies, though this may turn out to be the case (see 183 ) . Equally challenging will be the study of more subtle, but pervasive changes that affect cranial soft tissues and bones of the facial skeleton and neurocranium in craniosynostosis conditions. As we move forward, evaluating the causative role of newly discovered craniosynostosis mutations, it is critical to remember that genes routinely function in the development of many tissues, and that a dynamic architecture of interacting factors -genetic and nongenetic-underlies the development of any complex trait 184 . Beyond the significant strides by many researchers whose work we have reviewed, that architecture remains largely unknown. Labels for the various facial bones in these species can be found elsewhere 46, 263 . The interparietal bone in mice is analogous to the most superior segment of the squamosal portion of the occipital bone in humans. The premaxilla is a separate bone in mice but is fused with the maxilla prior to birth in humans. 
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